Joint with: Stromal Immunology in Health and Disease
Fibrosis: Cross Organ Pathology and Pathways to Clinical Development
January 1-4, 2026 | Location to be Determined
Scientific Organizers:
Florian Rieder, Tatiana Kisseleva and Marco Prunotto
In Person
On Demand
January 1-4, 2026 | Location to be Determined
Scientific Organizers:
Florian Rieder, Tatiana Kisseleva and Marco Prunotto
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Thursday, January 1, 2026
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Friday, January 2, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address (Joint)
8:00–9:00 AM
Thomas A Wynn †, Pfizer
The Future of Anti-Fibrotic Therapy: Scar Macs and Beyond
The Future of Anti-Fibrotic Therapy: Scar Macs and Beyond
From Fibroblasts to Fibrosis, and Back Again (Joint)
9:00–11:15 AM
Boris Hinz †, St. Michael's Hospital and University of Toronto
To Push or Pull? How the Mechanical Environment Affects Stromal Activation
To Push or Pull? How the Mechanical Environment Affects Stromal Activation
Sheila A. Stewart †, Washington University School of Medicine
Stromal Reprogramming Sensitizing Metastatic Breast Cancer to Immunotherapy
Stromal Reprogramming Sensitizing Metastatic Breast Cancer to Immunotherapy
Michael B. Brenner, Harvard Medical School
Notch and Wnt Signaling in Inflammatory Fibroblast-Mediated Pathology
Notch and Wnt Signaling in Inflammatory Fibroblast-Mediated Pathology
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Workshop 1
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Mechanisms of the Extracellular Matrix Environment Driving Disease
5:00–7:00 PM
Rachel Lennon †, University of Manchester
The Matrisome in Disease Pathology
The Matrisome in Disease Pathology
Natalie J. Torok †, Stanford University
Viscoelasticity Promoting Cancer Progression
Viscoelasticity Promoting Cancer Progression
Karine Clément †, INSERM / Sorbonne Universite
Microenvironment and Mechanosensing Influencing Adipose Tissue Function
Microenvironment and Mechanosensing Influencing Adipose Tissue Function
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Saturday, January 3, 2026
Breakfast
7:00–8:00 AM
Fibroblast Heterogenity across Organs: A Critical Basis for Discovery and Therapy Translation
8:00–10:30 AM
Suzanne Devkota †, Cedars-Sinai Medical Center
Microbiome Influence on Adipose Tissue Fibrosis
Microbiome Influence on Adipose Tissue Fibrosis
Florian Rieder, Cleveland Clinic
Fibroblast interactions in Intestinal Fibrosis
Fibroblast interactions in Intestinal Fibrosis
Stefanie Dimmeler †, University of Frankfurt
Persistent Fibroblast Activation in the Hypertrophic Human Heart
Persistent Fibroblast Activation in the Hypertrophic Human Heart
Dean Sheppard †, University of California, San Francisco
The Alveolar Fibroblast Lineage in Lung Inflammation and Fibrosis
The Alveolar Fibroblast Lineage in Lung Inflammation and Fibrosis
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Panel Discussion 1: Fibroblast Heterogeneity Across Organs
10:30–11:00 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
1:00–10:00 PM
Coffee Available
4:30–5:00 PM
Mechanisms that Drive the Progression and Regression of Fibrosis
5:00–7:00 PM
Scott L. Friedman †, Icahn School of Medicine at Mount Sinai
Genetics linked with Fibrosis: Commonalities and Differences across Organs
Genetics linked with Fibrosis: Commonalities and Differences across Organs
Pilar Alcaide †, Tufts University School of Medicine
The Crossroad of Inflammation and Fibrosis: Fibroblast and Immune Cell Interactions
The Crossroad of Inflammation and Fibrosis: Fibroblast and Immune Cell Interactions
Tatiana Kisseleva, University of California, San Diego
Mechanisms of Regression of Liver Fibrosis
Mechanisms of Regression of Liver Fibrosis
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Sunday, January 4, 2026
Breakfast
7:00–8:00 AM
Drug Development Pathways for Fibrosis – From Mechanisms to Medicine
8:00–10:30 AM
David Brenner †, Sanford Burnham Prebys
Preclinical Models of Fibrosis: Are we able to Predict Therapy Response
Preclinical Models of Fibrosis: Are we able to Predict Therapy Response
Marco Prunotto, Medicxi
Drug Development Pathways for Fibrotic Diseases: Lessons Learned
Drug Development Pathways for Fibrotic Diseases: Lessons Learned
Faye Feller †, Geron Corporation
Targeting Telomerase to Treat Fibrotic Diseases
Targeting Telomerase to Treat Fibrotic Diseases
Sujata Rao †, Insilico Medicine
The Future is Here: AI in the Discovery and Development of Anti-Fibrotic Drugs
The Future is Here: AI in the Discovery and Development of Anti-Fibrotic Drugs
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Panel Discussion 2: Preclincial Evaluation and Clincial Development in Fibrotic Diseases
10:30–11:00 AM
On Own for Lunch
11:00–5:00 PM
Workshop 2
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Therapeutic Modulation of Stromal Cell Function (Joint)
5:00–6:45 PM
Viviana Cremasco, Novartis Biomedical Research
TGFb Neutralization and Tumor Stroma Modulation: From Bench to Bed
TGFb Neutralization and Tumor Stroma Modulation: From Bench to Bed
Yuval Rinkevich †, Helmholtz Zentrum München, GmbH
Regenerative Medicine and Tissue Repair
Regenerative Medicine and Tissue Repair
Moises Selman †, Instituto Nacional de Enfermedades Respiratorias
Fibroblast-Epithelial Crosstalk in Lung Disease
Fibroblast-Epithelial Crosstalk in Lung Disease
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Monday, January 5, 2026
Departure
12:00–11:59 PM
Subscribe for Updates